CompletedPhase 1NCT02767128

Pharmacokinetics and Absolute Bioavailability of Fer-In-Sol and Triferic Administered Orally With Shohl's Solution in Healthy Volunteers

Studying IRIDA syndrome

Last synced from ClinicalTrials.gov May 13, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Rockwell Medical Technologies, Inc.
Principal Investigator: Raymond D Pratt, MD, FACP
Rockwell Medical, Inc
Intervention: Triferic(drug)
Enrollment: 14 enrolled
Eligibility: 18-65 years · All sexes
Timeline: 2016 – 2016

Study locations (1)

Jasper Clinic, Kalamazoo, Michigan, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02767128 on ClinicalTrials.gov

← Back to all trials